• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Anti-Alzheimer's Disease Drugs (Cholinesterase Inhibitors, and NMDARA), and Anti-Parkinson's Disease Drugs (Dopaminergic Agents, and Dopamine Agonists) Are Classified Inside 2006 Global Strategic Business Report

Posted on: Monday, 27 November 2006, 12:01 CST

Research and Markets (http://www.researchandmarkets.com/reports/c45944) has announced the addition of Alzheimers and Parkinsons Disease - Global Strategic Business Report to their offering.

This report analyzes the worldwide markets for Alzheimer's and Parkinson's Disease in Millions of US$. The Major product classes Analyzed are Anti-Alzheimer's Disease Drugs (Cholinesterase Inhibitors, and NMDARA), and Anti-Parkinson's Disease Drugs (Dopaminergic Agents, and Dopamine Agonists). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2010. The report profiles 72 companies including many key and niche players worldwide. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Content Outline

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. EXECUTIVE SUMMARY

1. Outlook

2. Neurodegenerative Diseases Market

3. Alzheimer's Market Overview

4. Parkinson's Disease Market Overview

5. Disease Overview

6. Drug Classification

7. Future Therapies

8. Recent Industry Activity

9. Focus on Select Players

10. Global Market Perspective

III. MARKET

1. United States

2. Canada

3. Japan

4. Europe

5. Rest of World

IV. COMPETITION

The Companies mentioned inside this report include:

Amarin Corporation PLC (UK)

Amorfix Life Sciences Ltd (Canada)

Apotex, Inc (Canada)

Asterand PLC (UK)

Avicena Group, Inc (USA)

Avigen, Inc (USA)

Axonyx, Inc (USA)

Boehringer Ingelheim GmbH (Germany)

Boehringer Ingelheim Pharmaceuticals, Inc (USA)

Boehringer Ingelheim (Egypt)

Brainstorm Cell Therapeutics, Inc (USA)

Bristol-Myers Squibb Company (USA)

Bristol-Myers Squibb GmbH & Co KgaA (Germany):

CeNeS Pharmaceuticals PLC (England)

Cephalon, Inc (USA)

Ceregene, Inc (USA)

Cita Neuropharmaceuticals, Inc (Canada)

CMI India Pvt, Limited (India)

Comtan (Canada)

Desitin Arzneimittel GmbH (Germany)

Draxis Health, Inc (Canada)

Eisai Co, Ltd (Japan)

Eisai, Inc (USA)

Eli Lilly and Company (USA)

Eli Lilly and Company Limited (UK)

Epix Pharmaceuticals (USA)

Ester Neurosciences Ltd (Israel)

Exelon (USA)

F Hoffmann-La Roche Ltd (Switzerland)

Forest Laboratories, Inc (USA)

Forest Pharmaceuticals Inc (USA)

Gerolymatos P N, SA (Greece)

GlaxoSmithKline PLC (UK)

GlaxoSmithkline NZ Ltd (New Zealand)

Glaxosmithkline SpA (Italy)

H Lundbeck AS (Denmark)

Lundbeck Espana SA (Spain)

Impax Laboratories, Inc (USA)

Johnson & Johnson (USA)

Johnson & Johnson Pharmaceutical Research & Development

LLC (USA)

Janssen LP (USA)

Kyowa Hakko Kogyo Co, Ltd (Japan)

Medtronic, Inc (USA)

Merck & Co, Inc (USA)

Merz Pharmaceuticals GmbH (Germany)

Mirapex (USA)

Myriad Genetics, Inc (USA)

Neuren Pharmaceuticals Limited (New Zealand)

Neurim Pharmaceuticals () Ltd (Israel)

Neurochem, Inc (Canada)

Neurologix, Inc (USA)

Newron Pharmaceuticals SpA (Italy)

Novartis AG (Switzerland)

Novartis Pharmaceuticals Corporation (USA)

Novartis Deutschland GmbH (Germany)

Novartis Pharma GmbH (Germany)

NsGene A/S (Denmark)

Nymox Pharmaceutical Corporation (Canada)

Orion Corporation (Finland)

Ortho-McNeil Neurologics, Inc (USA)

Pfizer, Inc (USA)

Pfizer Australia Pty, Ltd (Australia)

Pfizer Manufacturing Belgium NV (Belgium)

Pharmacopeia Drug Discovery, Inc (USA)

Pharmaline Sal (Lebanon)

ReGen Therapeutics PLC (UK)

ReNeuron Ltd (UK)

Richter Gedeon (Hungary)

Samaritan Pharmaceuticals, Inc (USA)

Sanofi-Aventis (France)

Schering España SA (Spain)

Sciele Pharma, Inc (USA)

Senexis Limited (UK)

Shire Pharmaceuticals Group PLC (UK)

Somerset Pharmaceuticals, Inc (USA)

Stalevo (USA)

StemCells, Inc (USA)

Terapia (Romania)

Teva Pharmaceutical Industries Ltd (Israel)

Titan Pharmaceuticals, Inc (USA)

TorreyPines Therapeutics (USA)

Unipharm Ltd (Israel)

Valeant Pharmaceuticals International (USA)

Vernalis PLC (UK)

Voyager Pharmaceutical Corporation (USA)

Wyeth (USA)

Zentiva AS Praha (Czech Republic)

Zhejiang Yixin Pharmaceutical Company Limited (China)

For more information visit http://www.researchandmarkets.com/reports/c45944

Source: Business Wire

More News in this Category